Symbols / PAVM Stock $9.17 -2.24% PAVmed Inc.
PAVM (Stock) Chart
About
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York
Stock Fundamentals
Scroll to Statements| Market Cap | 57.91M | Enterprise Value | 82.32M | Income | -3.77M | Sales | 71.00K | Book/sh | 10.01 | Cash/sh | 0.31 |
| Dividend Yield | — | Payout | 0.00% | Employees | 41 | IPO | — | P/E | — | Forward P/E | -3.35 |
| PEG | — | P/S | 815.66 | P/B | 0.92 | P/C | — | EV/EBITDA | -3.79 | EV/Sales | 1159.42 |
| Quick Ratio | 0.13 | Current Ratio | 0.17 | Debt/Eq | 59.86 | LT Debt/Eq | — | EPS (ttm) | -5.63 | EPS next Y | -2.74 |
| EPS Growth | — | Revenue Growth | 4.20% | Earnings | 2026-05-14 | ROA | -39.24% | ROE | -32.34% | ROIC | — |
| Gross Margin | -207.04% | Oper. Margin | -130.83% | Profit Margin | 5.65% | Shs Outstand | 6.32M | Shs Float | 2.75M | Short Float | 0.38% |
| Short Ratio | 1.27 | Short Interest | — | 52W High | 28.44 | 52W Low | 6.00 | Beta | 0.81 | Avg Volume | 81.50K |
| Volume | 16.46K | Target Price | $40.50 | Recom | Strong_buy | Prev Close | $9.38 | Price | $9.17 | Change | -2.24% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-09 | main | Ascendiant Capital | Buy → Buy | $65 |
| 2025-12-10 | main | Ascendiant Capital | Buy → Buy | $17 |
| 2025-10-06 | main | Ascendiant Capital | Buy → Buy | $20 |
| 2025-06-06 | main | Ascendiant Capital | Buy → Buy | $19 |
| 2025-04-21 | main | Ascendiant Capital | Buy → Buy | $20 |
| 2024-12-09 | main | Ascendiant Capital | Buy → Buy | $19 |
- Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock - PR Newswire hu, 23 Apr 2026 12
- PAVmed (NASDAQ: PAVM) registers 9.23M common shares; $30M potential from warrants - Stock Titan ue, 21 Apr 2026 10
- PAVmed (PAVM) Stock Resistance Rejection (+0.11%) 2026-04-18 - Fundamental Analysis - Cổng thông tin điện tử tỉnh Tây Ninh Sat, 18 Apr 2026 22
- PAVmed (PAVM) Upgraded to Strong Buy: Here's Why - Yahoo Finance Fri, 10 Oct 2025 07
- PAVmed Inc. (PAVM) posts narrow Q4 2025 EPS miss, shares edge higher in muted investor trading. - Viral Trade Signals - Cổng thông tin điện tử Tỉnh Sơn La hu, 23 Apr 2026 00
- PAVmed Announces Reverse Stock Split - PR Newswire ue, 30 Dec 2025 08
- PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know - Yahoo Finance Mon, 30 Mar 2026 07
- 70,000-share PAVmed (PAVM) restricted stock grant to CMO - Stock Titan Mon, 13 Apr 2026 07
- Will PAVmed (PAVM) Stock Miss Expectations | Price at $9.97, Up 1.27% - Community Exit Signals - Cổng thông tin điện tử Tỉnh Sơn La Mon, 06 Apr 2026 07
- PAVM Assigns Joseph Virgilio to Lead Medical Device Portfolio Relaunch - Yahoo Finance ue, 07 Apr 2026 07
- PAVmed (PAVM) director gets 13,930-share restricted stock grant - Stock Titan Fri, 03 Apr 2026 07
- PAVmed Inc. (PAVM) posts narrow Q4 2025 EPS miss, shares edge higher in muted investor trading. - Community Exit Signals - Cổng thông tin điện tử tỉnh Tây Ninh hu, 23 Apr 2026 06
- [Form 3] PAVmed Inc. Initial Statement of Beneficial Ownership - Stock Titan Mon, 13 Apr 2026 07
- Tasso Partners, LLC (PAVM) reports large PAVmed stake and warrant position - Stock Titan Mon, 06 Apr 2026 07
- Lucid CEO to speak at Needham healthcare conference on April 16 - Stock Titan hu, 09 Apr 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.07
-97.63%
|
3.00
+22.15%
|
2.45
+550.40%
|
0.38
|
| Operating Revenue |
|
0.07
-97.63%
|
3.00
+22.15%
|
2.45
+550.40%
|
0.38
|
| Cost Of Revenue |
|
0.22
-95.50%
|
4.84
-24.61%
|
6.42
+77.64%
|
3.61
|
| Reconciled Cost Of Revenue |
|
0.11
-97.31%
|
4.20
-23.74%
|
5.51
+87.32%
|
2.94
|
| Gross Profit |
|
-0.15
+92.03%
|
-1.84
+53.50%
|
-3.97
-22.58%
|
-3.24
|
| Operating Expense |
|
21.24
-50.06%
|
42.53
-34.39%
|
64.83
-26.21%
|
87.85
|
| Research And Development |
|
4.49
-24.28%
|
5.93
-58.45%
|
14.28
-43.66%
|
25.34
|
| Selling General And Administration |
|
17.17
-52.51%
|
36.15
-25.51%
|
48.53
-20.09%
|
60.73
|
| Selling And Marketing Expense |
|
0.92
-92.11%
|
11.63
-33.87%
|
17.58
-8.98%
|
19.32
|
| General And Administrative Expense |
|
16.25
-33.74%
|
24.52
-20.75%
|
30.95
-25.27%
|
41.41
|
| Other Gand A |
|
16.25
-33.74%
|
24.52
-20.75%
|
30.95
-25.27%
|
41.41
|
| Other Operating Expenses |
|
-0.42
-281.65%
|
-0.11
|
—
|
—
|
| Total Expenses |
|
21.46
-54.70%
|
47.37
-33.51%
|
71.25
-22.10%
|
91.46
|
| Operating Income |
|
-21.39
+51.80%
|
-44.38
+35.49%
|
-68.80
+24.47%
|
-91.09
|
| Total Operating Income As Reported |
|
-21.81
+50.98%
|
-44.49
+35.33%
|
-68.80
+24.47%
|
-91.09
|
| EBITDA |
|
-2.34
-107.90%
|
29.67
+139.17%
|
-75.74
+23.88%
|
-99.50
|
| Normalized EBITDA |
|
-2.29
+94.00%
|
-38.08
+47.52%
|
-72.57
+22.85%
|
-94.07
|
| Reconciled Depreciation |
|
0.10
-91.24%
|
1.20
-59.14%
|
2.93
+19.33%
|
2.46
|
| EBIT |
|
-2.45
-108.60%
|
28.47
+136.19%
|
-78.67
+22.84%
|
-101.96
|
| Total Unusual Items |
|
-0.06
-100.09%
|
67.75
+2235.94%
|
-3.17
+41.63%
|
-5.43
|
| Total Unusual Items Excluding Goodwill |
|
-0.06
-100.09%
|
67.75
+2235.94%
|
-3.17
+41.63%
|
-5.43
|
| Special Income Charges |
|
-0.06
-100.09%
|
67.75
+2535.37%
|
-2.78
+48.80%
|
-5.43
|
| Other Special Charges |
|
0.06
-98.72%
|
4.54
+19.91%
|
3.78
-30.40%
|
5.43
|
| Net Income |
|
0.40
-98.99%
|
39.79
+162.00%
|
-64.17
+27.88%
|
-88.98
|
| Pretax Income |
|
-2.47
-108.69%
|
28.43
+135.86%
|
-79.26
+23.22%
|
-103.24
|
| Net Non Operating Interest Income Expense |
|
0.01
-96.17%
|
0.21
+348.81%
|
-0.08
+92.45%
|
-1.11
|
| Interest Expense Non Operating |
|
0.02
-53.33%
|
0.04
-92.36%
|
0.59
-54.02%
|
1.28
|
| Net Interest Income |
|
0.01
-96.17%
|
0.21
+348.81%
|
-0.08
+92.45%
|
-1.11
|
| Interest Expense |
|
0.02
-53.33%
|
0.04
-92.36%
|
0.59
-54.02%
|
1.28
|
| Interest Income Non Operating |
|
0.03
-88.58%
|
0.25
-49.70%
|
0.51
+198.82%
|
0.17
|
| Interest Income |
|
0.03
-88.58%
|
0.25
-49.70%
|
0.51
+198.82%
|
0.17
|
| Other Income Expense |
|
18.91
-73.95%
|
72.60
+799.11%
|
-10.38
+5.93%
|
-11.04
|
| Other Non Operating Income Expenses |
|
10.49
+143.23%
|
4.31
+159.79%
|
-7.21
-28.67%
|
-5.61
|
| Gain On Sale Of Security |
|
—
|
0.46
+218.46%
|
-0.39
+69.36%
|
-1.27
|
| Gain On Sale Of Business |
|
0.00
-100.00%
|
72.29
|
0.00
|
—
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-2.47
-108.69%
|
28.43
+135.86%
|
-79.26
+23.22%
|
-103.24
|
| Net Income From Continuing Operation Net Minority Interest |
|
0.40
-98.99%
|
39.79
+162.00%
|
-64.17
+27.88%
|
-88.98
|
| Net Income From Continuing And Discontinued Operation |
|
0.40
-98.99%
|
39.79
+162.00%
|
-64.17
+27.88%
|
-88.98
|
| Net Income Continuous Operations |
|
-2.47
-108.69%
|
28.43
+135.86%
|
-79.26
+23.22%
|
-103.24
|
| Minority Interests |
|
2.87
-74.74%
|
11.36
-24.68%
|
15.09
+5.84%
|
14.26
|
| Normalized Income |
|
0.46
+101.64%
|
-27.96
+54.16%
|
-61.00
+26.99%
|
-83.55
|
| Net Income Common Stockholders |
|
-3.77
-111.81%
|
31.97
+148.24%
|
-66.27
+25.76%
|
-89.26
|
| Otherunder Preferred Stock Dividend |
|
—
|
0.00
-100.00%
|
1.79
|
0.00
|
| Diluted EPS |
|
-5.63
-137.53%
|
15.00
+105.46%
|
-274.80
+39.06%
|
-450.90
|
| Basic EPS |
|
-5.63
-105.80%
|
97.11
+135.34%
|
-274.80
+39.06%
|
-450.90
|
| Basic Average Shares |
|
0.67
+79.61%
|
0.37
+54.86%
|
0.24
+21.78%
|
0.20
|
| Diluted Average Shares |
|
0.67
+79.61%
|
0.37
+54.86%
|
0.24
+21.78%
|
0.20
|
| Diluted NI Availto Com Stockholders |
|
-3.77
-111.65%
|
32.39
+148.88%
|
-66.27
+25.76%
|
-89.26
|
| Average Dilution Earnings |
|
0.00
-100.00%
|
0.43
|
—
|
—
|
| Amortization |
|
0.00
-100.00%
|
0.56
-72.34%
|
2.02
+13.28%
|
1.78
|
| Amortization Of Intangibles Income Statement |
|
0.00
-100.00%
|
0.56
-72.34%
|
2.02
+13.28%
|
1.78
|
| Depreciation Amortization Depletion Income Statement |
|
0.00
-100.00%
|
0.56
-72.34%
|
2.02
+13.28%
|
1.78
|
| Depreciation And Amortization In Income Statement |
|
0.00
-100.00%
|
0.56
-72.34%
|
2.02
+13.28%
|
1.78
|
| Earnings From Equity Interest |
|
8.48
+1494.55%
|
0.53
|
0.00
|
—
|
| Gain On Sale Of PPE |
|
—
|
0.00
-100.00%
|
1.00
|
0.00
|
| Preferred Stock Dividends |
|
4.17
-46.65%
|
7.83
+2474.01%
|
0.30
+8.19%
|
0.28
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
38.81
+26.59%
|
30.66
-7.42%
|
33.12
-38.65%
|
53.98
|
| Current Assets |
|
2.56
+18.16%
|
2.16
-91.17%
|
24.50
-44.23%
|
43.93
|
| Cash Cash Equivalents And Short Term Investments |
|
1.54
+29.79%
|
1.19
-93.97%
|
19.64
-50.59%
|
39.74
|
| Cash And Cash Equivalents |
|
1.54
+29.79%
|
1.19
-93.97%
|
19.64
-50.59%
|
39.74
|
| Cash Financial |
|
1.54
+29.79%
|
1.19
-93.97%
|
19.64
-50.59%
|
39.74
|
| Receivables |
|
0.01
-16.67%
|
0.02
-70.49%
|
0.06
+258.82%
|
0.02
|
| Accounts Receivable |
|
0.01
-16.67%
|
0.02
-70.49%
|
0.06
+258.82%
|
0.02
|
| Inventory |
|
0.24
-10.15%
|
0.27
-50.65%
|
0.54
+106.51%
|
0.26
|
| Raw Materials |
|
0.24
-10.15%
|
0.27
+1.92%
|
0.26
+74.00%
|
0.15
|
| Prepaid Assets |
|
0.77
+10.07%
|
0.69
-83.68%
|
4.26
+9.09%
|
3.90
|
| Other Current Assets |
|
—
|
—
|
—
|
—
|
| Total Non Current Assets |
|
36.26
+27.23%
|
28.50
+230.54%
|
8.62
-14.25%
|
10.05
|
| Net PPE |
|
2.08
-21.58%
|
2.65
-56.18%
|
6.05
+10.24%
|
5.49
|
| Gross PPE |
|
3.44
-11.96%
|
3.90
-49.75%
|
7.77
+23.40%
|
6.30
|
| Accumulated Depreciation |
|
-1.36
-8.38%
|
-1.25
+27.11%
|
-1.72
-112.75%
|
-0.81
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.88
+3.66%
|
0.85
-31.00%
|
1.23
+5.67%
|
1.16
|
| Construction In Progress |
|
0.00
+0.00%
|
0.00
-87.50%
|
0.02
-46.67%
|
0.03
|
| Other Properties |
|
2.56
-16.31%
|
3.05
-53.19%
|
6.52
+27.86%
|
5.10
|
| Leases |
|
0.00
+0.00%
|
0.00
-50.00%
|
0.00
+0.00%
|
0.00
|
| Goodwill And Other Intangible Assets |
|
—
|
0.00
-100.00%
|
1.42
-58.66%
|
3.44
|
| Other Intangible Assets |
|
—
|
—
|
1.42
-58.66%
|
3.44
|
| Investments And Advances |
|
34.12
+33.09%
|
25.64
|
0.00
|
—
|
| Long Term Equity Investment |
|
34.12
+33.09%
|
25.64
|
0.00
|
—
|
| Other Non Current Assets |
|
0.06
-73.08%
|
0.21
-81.87%
|
1.15
+2.32%
|
1.12
|
| Total Liabilities Net Minority Interest |
|
16.51
-56.19%
|
37.69
-34.03%
|
57.14
+32.73%
|
43.05
|
| Current Liabilities |
|
14.84
-58.14%
|
35.45
-34.57%
|
54.18
+31.50%
|
41.20
|
| Payables And Accrued Expenses |
|
1.20
-72.31%
|
4.32
-15.76%
|
5.13
+14.75%
|
4.47
|
| Payables |
|
0.68
+3.20%
|
0.66
-63.21%
|
1.79
-33.95%
|
2.70
|
| Accounts Payable |
|
0.68
+3.20%
|
0.66
-63.21%
|
1.79
-33.95%
|
2.70
|
| Current Accrued Expenses |
|
0.52
-85.86%
|
3.66
+9.61%
|
3.34
+89.35%
|
1.76
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
1.20
+4.17%
|
1.15
-54.09%
|
2.51
+29.23%
|
1.94
|
| Current Debt And Capital Lease Obligation |
|
11.67
-60.58%
|
29.61
-35.29%
|
45.77
+31.54%
|
34.79
|
| Current Debt |
|
11.10
-61.86%
|
29.10
-34.16%
|
44.20
+31.35%
|
33.65
|
| Other Current Borrowings |
|
11.10
-61.86%
|
29.10
-34.16%
|
44.20
+31.35%
|
33.65
|
| Current Capital Lease Obligation |
|
0.57
+11.70%
|
0.51
-67.22%
|
1.56
+37.16%
|
1.14
|
| Other Current Liabilities |
|
0.77
+112.43%
|
0.36
-53.41%
|
0.78
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
1.68
-25.46%
|
2.25
-24.09%
|
2.96
+60.35%
|
1.85
|
| Long Term Debt And Capital Lease Obligation |
|
1.68
-25.46%
|
2.25
-24.09%
|
2.96
+60.35%
|
1.85
|
| Long Term Capital Lease Obligation |
|
1.68
-25.46%
|
2.25
-24.09%
|
2.96
+60.35%
|
1.85
|
| Stockholders Equity |
|
33.97
+1461.40%
|
-2.50
+95.37%
|
-53.83
-456.05%
|
-9.68
|
| Common Stock Equity |
|
9.29
+259.85%
|
-5.81
+89.77%
|
-56.82
-359.15%
|
-12.38
|
| Capital Stock |
|
24.68
+644.02%
|
3.32
+10.49%
|
3.00
+11.14%
|
2.70
|
| Common Stock |
|
0.00
+0.00%
|
0.00
-88.89%
|
0.01
+50.00%
|
0.01
|
| Preferred Stock |
|
24.68
+644.21%
|
3.32
+10.79%
|
2.99
+11.06%
|
2.69
|
| Share Issued |
|
0.93
+148.58%
|
0.37
+30.55%
|
0.29
+36.15%
|
0.21
|
| Ordinary Shares Number |
|
0.93
+148.58%
|
0.37
+30.55%
|
0.29
+36.15%
|
0.21
|
| Additional Paid In Capital |
|
268.02
+7.57%
|
249.15
+4.86%
|
237.60
+9.90%
|
216.19
|
| Retained Earnings |
|
-258.73
-1.48%
|
-254.97
+13.40%
|
-294.43
-29.04%
|
-228.17
|
| Treasury Stock |
|
—
|
—
|
0.00
-100.00%
|
0.41
|
| Minority Interest |
|
-11.67
-157.10%
|
-4.54
-115.22%
|
29.81
+44.62%
|
20.61
|
| Total Equity Gross Minority Interest |
|
22.30
+417.08%
|
-7.03
+70.72%
|
-24.02
-319.66%
|
10.93
|
| Total Capitalization |
|
33.97
+1461.40%
|
-2.50
+95.37%
|
-53.83
-456.05%
|
-9.68
|
| Working Capital |
|
-12.28
+63.10%
|
-33.28
-12.14%
|
-29.68
-1188.74%
|
2.73
|
| Invested Capital |
|
20.39
-12.45%
|
23.29
+284.48%
|
-12.62
-159.34%
|
21.27
|
| Total Debt |
|
13.35
-58.10%
|
31.86
-34.61%
|
48.73
+32.99%
|
36.64
|
| Net Debt |
|
9.56
-65.75%
|
27.91
+13.66%
|
24.56
|
—
|
| Capital Lease Obligations |
|
2.25
-18.55%
|
2.76
-39.01%
|
4.53
+51.49%
|
2.99
|
| Net Tangible Assets |
|
33.97
+1461.40%
|
-2.50
+95.48%
|
-55.26
-320.96%
|
-13.13
|
| Tangible Book Value |
|
9.29
+259.85%
|
-5.81
+90.02%
|
-58.25
-268.17%
|
-15.82
|
| Current Notes Payable |
|
—
|
—
|
—
|
—
|
| Other Inventories |
|
—
|
—
|
0.28
+150.45%
|
0.11
|
| Preferred Stock Equity |
|
24.68
+644.21%
|
3.32
+10.79%
|
2.99
+11.06%
|
2.69
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-5.21
+84.48%
|
-33.55
+35.52%
|
-52.04
+26.69%
|
-70.98
|
| Cash Flow From Continuing Operating Activities |
|
-5.21
+84.48%
|
-33.55
+35.52%
|
-52.04
+26.69%
|
-70.98
|
| Net Income From Continuing Operations |
|
-2.47
-108.69%
|
28.43
+135.86%
|
-79.26
+23.22%
|
-103.24
|
| Depreciation Amortization Depletion |
|
0.10
-91.24%
|
1.20
-59.14%
|
2.93
+19.33%
|
2.46
|
| Depreciation |
|
0.10
-83.57%
|
0.64
-29.86%
|
0.91
|
—
|
| Amortization Cash Flow |
|
0.00
-100.00%
|
0.56
-72.34%
|
2.02
|
—
|
| Depreciation And Amortization |
|
0.10
-91.24%
|
1.20
-59.14%
|
2.93
+19.33%
|
2.46
|
| Amortization Of Intangibles |
|
0.00
-100.00%
|
0.56
-72.34%
|
2.02
|
—
|
| Other Non Cash Items |
|
3.78
+2523.61%
|
0.14
-98.36%
|
8.78
+58.37%
|
5.55
|
| Stock Based Compensation |
|
1.71
-73.53%
|
6.45
-42.10%
|
11.14
-42.97%
|
19.53
|
| Operating Gains Losses |
|
-8.43
+88.01%
|
-70.28
-2626.38%
|
2.78
-48.80%
|
5.43
|
| Gain Loss On Sale Of PPE |
|
—
|
0.00
+100.00%
|
-1.00
|
0.00
|
| Change In Working Capital |
|
0.10
-80.86%
|
0.51
-67.82%
|
1.59
+322.21%
|
-0.72
|
| Change In Receivables |
|
0.00
-93.02%
|
0.04
+197.73%
|
-0.04
-124.04%
|
0.18
|
| Changes In Account Receivables |
|
0.00
-93.02%
|
0.04
+197.73%
|
-0.04
-124.04%
|
0.18
|
| Change In Prepaid Assets |
|
0.11
-86.90%
|
0.83
+438.21%
|
-0.25
-161.96%
|
0.40
|
| Change In Payables And Accrued Expense |
|
-0.01
+96.14%
|
-0.36
-119.30%
|
1.88
+245.14%
|
-1.30
|
| Change In Accrued Expense |
|
-0.04
+87.50%
|
-0.30
-110.86%
|
2.80
+605.23%
|
-0.55
|
| Change In Payable |
|
0.02
+140.68%
|
-0.06
+93.57%
|
-0.92
-23.72%
|
-0.74
|
| Change In Account Payable |
|
0.02
+140.68%
|
-0.06
+93.57%
|
-0.92
-23.72%
|
-0.74
|
| Investing Cash Flow |
|
-0.03
+99.81%
|
-16.18
-2235.09%
|
0.76
+115.99%
|
-4.74
|
| Cash Flow From Continuing Investing Activities |
|
-0.03
+99.81%
|
-16.18
-2235.09%
|
0.76
+115.99%
|
-4.74
|
| Net PPE Purchase And Sale |
|
-0.03
+43.64%
|
-0.06
+77.27%
|
-0.24
+84.29%
|
-1.54
|
| Purchase Of PPE |
|
-0.03
+43.64%
|
-0.06
+77.27%
|
-0.24
+84.29%
|
-1.54
|
| Capital Expenditure |
|
-0.03
+43.64%
|
-0.06
+77.27%
|
-0.24
+84.29%
|
-1.54
|
| Net Business Purchase And Sale |
|
0.00
+100.00%
|
-16.48
|
0.00
+100.00%
|
-3.20
|
| Purchase Of Business |
|
0.00
+100.00%
|
-16.48
|
0.00
+100.00%
|
-3.20
|
| Gain Loss On Sale Of Business |
|
0.00
+100.00%
|
-72.29
|
0.00
|
—
|
| Net Intangibles Purchase And Sale |
|
0.00
-100.00%
|
0.35
-65.00%
|
1.00
|
0.00
|
| Net Other Investing Changes |
|
—
|
—
|
—
|
-3.20
|
| Financing Cash Flow |
|
5.59
-82.13%
|
31.28
+0.36%
|
31.17
-18.42%
|
38.21
|
| Cash Flow From Continuing Financing Activities |
|
5.59
-82.13%
|
31.28
+0.36%
|
31.17
-18.42%
|
38.21
|
| Net Issuance Payments Of Debt |
|
0.00
+100.00%
|
-0.53
-105.35%
|
9.92
-71.84%
|
35.23
|
| Issuance Of Debt |
|
—
|
0.00
-100.00%
|
10.00
-71.61%
|
35.23
|
| Repayment Of Debt |
|
0.00
+100.00%
|
-0.53
-572.15%
|
-0.08
|
0.00
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
0.00
|
| Net Long Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Short Term Debt Issuance |
|
—
|
0.00
-100.00%
|
10.00
-71.61%
|
35.23
|
| Short Term Debt Payments |
|
0.00
+100.00%
|
-0.53
-572.15%
|
-0.08
|
0.00
|
| Net Short Term Debt Issuance |
|
0.00
+100.00%
|
-0.53
-105.35%
|
9.92
-71.84%
|
35.23
|
| Net Common Stock Issuance |
|
5.70
+256.63%
|
1.60
-12.05%
|
1.82
+19.54%
|
1.52
|
| Common Stock Payments |
|
—
|
—
|
0.00
+100.00%
|
-0.37
|
| Repurchase Of Capital Stock |
|
—
|
—
|
0.00
+100.00%
|
-0.37
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
0.42
-48.27%
|
0.81
-44.67%
|
1.46
|
| Net Other Financing Charges |
|
-0.11
|
—
|
—
|
—
|
| Changes In Cash |
|
0.35
+101.91%
|
-18.45
+8.21%
|
-20.11
+46.41%
|
-37.51
|
| Beginning Cash Position |
|
1.19
-93.97%
|
19.64
-50.59%
|
39.74
-48.56%
|
77.26
|
| End Cash Position |
|
1.54
+29.79%
|
1.19
-93.97%
|
19.64
-50.59%
|
39.74
|
| Free Cash Flow |
|
-5.24
+84.42%
|
-33.61
+35.71%
|
-52.28
+27.92%
|
-72.53
|
| Common Stock Issuance |
|
5.70
+256.63%
|
1.60
-12.05%
|
1.82
-3.66%
|
1.89
|
| Earnings Losses From Equity Investments |
|
-8.48
-1494.55%
|
-0.53
|
0.00
|
—
|
| Issuance Of Capital Stock |
|
5.70
-81.85%
|
31.40
+53.59%
|
20.44
+983.88%
|
1.89
|
| Net Preferred Stock Issuance |
|
0.00
-100.00%
|
29.80
+59.99%
|
18.62
|
0.00
|
| Preferred Stock Issuance |
|
0.00
-100.00%
|
29.80
+59.99%
|
18.62
|
0.00
|
| Sale Of Intangibles |
|
0.00
-100.00%
|
0.35
-65.00%
|
1.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-13 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 8-K2026-03-30 View
- 8-K2026-03-27 View
- 10-K2026-03-27 View
- 8-K2026-02-04 View
- 8-K2026-01-23 View
- 8-K2025-12-30 View
- 8-K2025-12-05 View
- 8-K2025-11-13 View
- 10-Q2025-11-12 View
- 42025-10-02 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|